医生如何管理抗素的FMF:来自高患病率国家的跨国调查的见解
Veysel Cam1, Dilara Unal2, Erdal Sag3
1V. Cam, MD, Hacettepe University, Department of Pediatrics, Division of Rheumatology, Ankara, Turkey.
The Journal of rheumatology
|January 15, 2026
概括
对于抗素的家族地中海热 (FMF) 最好采用生物疗法,通常选择卡纳基努马布. 临床医生面临着科尔奇辛合规性的挑战,并探索生物制剂的逐渐减少/停止策略.
科学领域:
- 类风湿病学 类风湿病学
- 临床免疫学临床免疫学
- 遗传学 是一个遗传学.
背景情况:
- 家庭地中海热 (FMF) 是一种遗传自发炎性疾病,需要长期管理.
- 科尔奇辛是第一线治疗,但耐药性需要生物制剂等替代疗法.
- 了解抗素耐药性FMF的现实生物用途对于优化患者护理至关重要.
研究的目的:
- 调查当前的临床实践,用于生物疗法,在耐素的FMF.
- 评估生物药物的治疗启动,逐渐减少和停止策略.
- 在FMF管理中识别与生物治疗相关的挑战.
主要方法:
- 在高FMF患病率的国家 (土耳其,以色列,意大利) 和德国,给儿科和成人类风湿病学家发送了一项29项调查.
- 调查的重点是对生物制剂的偏好,菌素的遵守,逐渐减少,以及治疗相关问题的管理.
- 分析了126名临床医生的回答,以了解现实世界的做法.
主要成果:
- 在没有监管问题的情况下,Canakinumab是首选的生物药物 (72.2%) 用于抗素耐药的FMF.
- 逐渐延长剂量间隔是生物制剂中最常见的逐渐减少策略.
- 超过一半的临床医生在开始使用生物药物后观察到菌素遵守度下降,成人风湿病学家对此更担心.
结论:
- 儿科风湿病学家倾向于停止生物治疗,而成人风湿病学家则倾向于终身使用.
- 按需生物使用已成为一种治疗策略.
- 未来的研究应该涉及对菌素的遵守性,FMF触发因素,以及在停止治疗后重新引入IL-1抑制剂的疗效.
相关概念视频
01:21Rheumatic Heart Disease III: Medical Management
289
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
289
01:17Pericarditis III: Medical Management
313
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
313
01:14Myocarditis III: Medical Management
175
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
175
01:23Gastritis III: Clinical Manifestations and Management
1.2K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.2K
01:22Myocarditis IV: Nursing Management
209
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
209
01:29Inflammatory Bowel Disease IV: Pharmacological Management
528
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
528